As neurotechnology expands our abilities to rejuvenate aging brains, rebound from trauma and enhance moods or sexual prowess, we need a consistent set of neuroethics about how that technology should be used.
Despite its controversy, World AIDS Day has demonstrated how vast and global the AIDS movement has gone. While the extent of AIDS advocacy was not as far-reaching then, in 1987 a burgeoning movement of health care practitioners and gay activists battled the FDA's questionable policies on AIDS drugs experimentation, which included excluding women and i.v. users from drug trials.
Flu vaccine is in short supply this season, and the reason is that
drug companies can't make as much money protecting us from disease as
from developing expensive treatments for niche illnesses.
Stewart Simonson is a former Amtrak corporate attorney
with zero medical experience. So why is he in charge of emergency
health and bioterrorism in the federal government?
It has all the makings of a horror flick, but panic over a
possible bird flu pandemic is following a time-honored script:
sensational media reports, profit-hungry drug manufacturers and
politicians eager to capitalize on fears.
The Gulf Coast hurricanes have raised new questions
about the integrity and competence of the American Red Cross to respond
to national emergencies. In this report from The Nation
archive, Linda Heller raised early alarms. July 1, 1996, issue
As Big Pharma increasingly turns to the Third World to test its products, this lush film will spark outrage, but glosses over the constant vigilance necessary to police drug trials.
The Supreme Court's medical marijuana decision was a major setback for common sense.
America remains unprepared for a possible avian flu
The FDA's refusal to issue a decision on Plan B reflects
the influence of the Christian right over Bush Administration policy.